JP2004503525A5 - - Google Patents

Download PDF

Info

Publication number
JP2004503525A5
JP2004503525A5 JP2002510429A JP2002510429A JP2004503525A5 JP 2004503525 A5 JP2004503525 A5 JP 2004503525A5 JP 2002510429 A JP2002510429 A JP 2002510429A JP 2002510429 A JP2002510429 A JP 2002510429A JP 2004503525 A5 JP2004503525 A5 JP 2004503525A5
Authority
JP
Japan
Prior art keywords
chem
trans
chiral
cispentacin
pharm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002510429A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004503525A (ja
JP3872427B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/006541 external-priority patent/WO2001096285A1/en
Publication of JP2004503525A publication Critical patent/JP2004503525A/ja
Publication of JP2004503525A5 publication Critical patent/JP2004503525A5/ja
Application granted granted Critical
Publication of JP3872427B2 publication Critical patent/JP3872427B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002510429A 2000-06-14 2001-06-08 β−アミノ酸ニトリル誘導体 Expired - Fee Related JP3872427B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00112577 2000-06-14
PCT/EP2001/006541 WO2001096285A1 (en) 2000-06-14 2001-06-08 Beta-amino acid nitrile derivatives

Publications (3)

Publication Number Publication Date
JP2004503525A JP2004503525A (ja) 2004-02-05
JP2004503525A5 true JP2004503525A5 (https=) 2005-02-03
JP3872427B2 JP3872427B2 (ja) 2007-01-24

Family

ID=8168969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002510429A Expired - Fee Related JP3872427B2 (ja) 2000-06-14 2001-06-08 β−アミノ酸ニトリル誘導体

Country Status (28)

Country Link
US (1) US6462076B2 (https=)
EP (1) EP1294679B1 (https=)
JP (1) JP3872427B2 (https=)
KR (1) KR20030029057A (https=)
CN (1) CN1324006C (https=)
AR (1) AR031594A1 (https=)
AT (1) ATE304997T1 (https=)
AU (2) AU2001266056B2 (https=)
BR (1) BR0111733A (https=)
CA (1) CA2410303C (https=)
DE (1) DE60113533T2 (https=)
EC (1) ECSP024383A (https=)
ES (1) ES2248346T3 (https=)
HR (1) HRP20020963A2 (https=)
HU (1) HUP0300896A3 (https=)
IL (1) IL153166A0 (https=)
JO (1) JO2234B1 (https=)
MA (1) MA26913A1 (https=)
MX (1) MXPA02012253A (https=)
NO (1) NO20025823D0 (https=)
NZ (1) NZ522587A (https=)
PE (1) PE20020064A1 (https=)
PL (1) PL359811A1 (https=)
RU (1) RU2245871C2 (https=)
UY (1) UY26769A1 (https=)
WO (1) WO2001096285A1 (https=)
YU (1) YU90802A (https=)
ZA (1) ZA200209415B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9916575D0 (en) * 1999-07-15 1999-09-15 Cambridge Combinatorial Ltd Solid phase nitrile synthesis
CA2439415C (en) * 2001-03-02 2011-09-20 Merck Frosst Canada & Co. Cathepsin cysteine protease inhibitors
JP2005502700A (ja) * 2001-09-13 2005-01-27 エフ.ホフマン−ラ ロシュ アーゲー Ccr−3受容体アンタゴニストv
HUP0402344A2 (hu) * 2001-12-04 2005-02-28 F. Hoffmann-La Roche Ag Helyettesített 2-amino-cikloalkán-karboxamidok, felhasználásuk cisztein-proteáz-inhibitorként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
US6759428B2 (en) * 2001-12-04 2004-07-06 Roche Palo Alto Llc Indole nitriles
ATE469645T1 (de) * 2002-10-23 2010-06-15 Bristol Myers Squibb Co Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv
RU2005141533A (ru) * 2003-06-02 2006-08-10 Ф.Хоффманн-Ля Рош Аг (Ch) Бензамиднитрильные производные
WO2005000793A1 (ja) * 2003-06-26 2005-01-06 Taisho Pharmaceutical Co., Ltd. 2位置換シクロアルキルカルボン酸誘導体
JP4690319B2 (ja) 2003-06-30 2011-06-01 メルク フロスト カナダ リミテツド カテプシンシステインプロテアーゼ阻害剤
EP1841730A4 (en) * 2005-01-19 2010-10-27 Merck Frosst Canada Ltd CATHEPSIN K INHIBITORS AND ATHEROSCLEROSIS
CN103172568A (zh) * 2005-07-06 2013-06-26 默克弗罗斯特加拿大有限公司 组织蛋白酶半胱氨酸蛋白酶抑制剂
EP2240491B1 (en) 2008-01-09 2015-07-15 Amura Therapeutics Limited TETRAHYDROFURO(2,3-b)PYRROL-3-ONE DERIVATIVES AS INHIBITORS OF CYSTEINE PROTEINASES
US7893099B2 (en) * 2009-06-11 2011-02-22 Hoffman-La Roche Inc. Cyclopentane derivatives
MY169319A (en) * 2011-07-26 2019-03-21 Sanofi Sa 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
CN103086923B (zh) * 2013-01-21 2014-04-23 吉林大学 肼腈类组织蛋白酶k抑制剂及其在治疗骨质疏松症方面的应用
CN105593230B (zh) * 2013-10-08 2018-07-06 默沙东公司 组织蛋白酶半胱氨酸蛋白酶抑制剂
NO2699580T3 (https=) 2014-01-24 2018-02-24
CN105837479B (zh) * 2016-04-05 2017-10-27 吉林大学 肼腈类组织蛋白酶k抑制剂及其在制备治疗骨关节炎药物中的应用
HUE070049T2 (hu) 2018-03-01 2025-05-28 Astrazeneca Ab (2S)-{(1S)-1-ciano-2-[4-(3-metil-2-oxo-2,3-dihidro-1,3-benzoxazol-5-il)fenil]etil} -1,4-oxazepán-2-karboxamidot tartalmazó gyógyászati készítmények
WO2020018547A1 (en) 2018-07-17 2020-01-23 Insmed Incorporated Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating lupus nephritis
CN113045491B (zh) * 2019-12-26 2024-09-06 罗欣药业(上海)有限公司 一种仑伐替尼及中间体的制备方法
CN115996923B (zh) 2020-08-26 2025-07-18 海思科医药集团股份有限公司 一种作为二肽基肽酶1抑制剂的腈衍生物及其用途
KR20230117738A (ko) 2020-12-04 2023-08-09 레이스톤 바이오파마 컴퍼니 리미티드 카텝신 c의 소분자 억제제 및 이의 의약적 용도
EP4538271A4 (en) 2022-06-07 2025-10-08 Reistone Biopharma Company Ltd POLYMORPH OF BENZO[C]CHROMANE COMPOUND, ITS PREPARATION METHOD AND ITS USE
TW202404961A (zh) 2022-06-07 2024-02-01 大陸商瑞石生物醫藥有限公司 苯并[c]色滿化合物的可藥用鹽、其多晶型及用途
JP2026503035A (ja) 2023-01-06 2026-01-27 インスメッド インコーポレイテッド 新規な可逆性dpp1阻害剤及びその用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177576B (en) 1975-06-02 1981-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 2-amino-cyclohexane carboxylic acid,its amides and similar compounds
HU185876B (en) * 1980-02-29 1985-04-28 Egyt Gyogyszervegyeszeti Gyar Composition for controlling growth of plants and process for producing the active agent
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
IT1283467B1 (it) 1996-07-19 1998-04-21 Menarini Farma Ind Derivati di cicloalcani 1,2 sostituiti come inibitori della trombina, procedimento per la loro preparazione e loro impiego in formulazioni
EP1024134A4 (en) * 1997-10-09 2003-05-14 Ono Pharmaceutical Co DERIVATIVES OF AMINOBUTANIC ACID
SK6572000A3 (en) 1997-11-05 2000-10-09 Novartis Ag Dipeptide nitriles, process for the preparation thereof, their use as medicaments and pharmaceutical composition comprising them

Similar Documents

Publication Publication Date Title
JP2004503525A5 (https=)
JP2001520998A5 (https=)
AU2002223640A1 (en) Fusion proteins as immunization treatments of alzheimer's disease
AU2003206413A1 (en) Substituted amino carboxamides for the treatment of alzheimer's disease
JP2002513761A5 (https=)
JP2001520991A5 (https=)
JPH10139702A5 (https=)
JP2003171388A5 (https=)
TWM278428U (en) Air cushion for exercise
WO2006014916A3 (en) Preparation of trandolapril
TH18368S1 (th) "กะทะล้อถอดได้"
GB0215757D0 (en) Benzoprostacyclin intermediates methods for their preparation and products derived therefrom
TH52753S (th) หัวไม้กอล์ฟ
TWD118854S1 (zh) 木質高爾夫球桿頭
TH77337S (th) เตาอบไมโครเวฟ
TH29574S1 (th) เตาอบไมโครเวฟ
TH78243S (th) "เตาอบไมโครเวฟ"
TH29575S1 (th) "เตาอบไมโครเวฟ"
TWD108710S1 (zh) 電視機(三十八)
TH25493S1 (th) เก้าอี้
TH79539S (th) เก้าอี้
TH88837S (th) อ่างอาบน้ำ
TH19692S1 (th) หัวฝักบัว
TH65049S (th) หัวฝักบัว
TH23937S1 (th) มือจับ